NSIM
PPH icon

North Star Investment Management’s VanEck Pharmaceutical ETF PPH Stock Holding History

North Star Investment Management’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$69.1K Hold
666
– – ﹤0.01% 663
2025
Q4 		$68.7K Sell
666
-89
-12% -$8.66K ﹤0.01% 610
2025
Q3 		$68.2K Sell
755
-354
-32% -$31K ﹤0.01% 597
2025
Q2 		$97.6K Buy
1,109
+1
+0.1% +$87 0.01% 526
2025
Q1 		$101K Hold
1,108
– – 0.01% 509
2024
Q4 		$95.6K Hold
1,108
– – 0.01% 515
2024
Q3 		$105K Buy
1,108
+61
+6% +$5.79K 0.01% 497
2024
Q2 		$95.8K Hold
1,047
– – 0.01% 506
2024
Q1 		$94.9K Buy
1,047
+1
+0.1% +$88 0.01% 515
2023
Q4 		$85.1K Hold
1,046
– – 0.01% 516
2023
Q3 		$83.5K Buy
1,046
+1
+0.1% +$81 0.01% 518
2023
Q2 		$82.3K Sell
1,045
-74
-7% -$5.79K 0.01% 533
2023
Q1 		$86.9K Hold
1,119
– – 0.01% 531
2022
Q4 		$87K Hold
1,119
– – 0.01% 506
2022
Q3 		$75K Buy
1,119
+141
+14% +$10.4K 0.01% 478
2022
Q2 		$75K Hold
978
– – 0.01% 489
2022
Q1 		$78K Hold
978
– – 0.01% 501
2021
Q4 		$75K Buy
978
+1
+0.1% +$74 0.01% 533
2021
Q3 		$71K Hold
977
– – 0.01% 527
2021
Q2 		$71K Buy
977
+1
+0.1% +$71 0.01% 524
2021
Q1 		$67K Hold
976
– – 0.01% 505
2020
Q4 		$65K Buy
976
+1
+0.1% +$64 0.01% 497
2020
Q3 		$61K Hold
975
– – 0.01% 481
2020
Q2 		$61K Buy
975
+1
+0.1% +$60 0.01% 465
2020
Q1 		$53K Sell
974
-283
-23% -$17.4K 0.01% 475
2019
Q4 		$81K Sell
1,257
-1,244
-50% -$75K 0.01% 467
2019
Q3 		$143K Buy
+2,501
New +$143K 0.02% 383
2019
Q2 		– Sell
-1,727
Closed -$105K – 794
2019
Q1 		$105K Sell
1,727
-877
-34% -$51.8K 0.01% 436
2018
Q4 		$143K Buy
2,604
+52
+2% +$3.15K 0.02% 370
2018
Q3 		$164K Sell
2,552
-146
-5% -$9.1K 0.02% 374
2018
Q2 		$159K Sell
2,698
-7
-0.3% -$406 0.02% 380
2018
Q1 		$154K Buy
2,705
+2,202
+438% +$132K 0.02% 379
2017
Q4 		$30K Sell
503
-88
-15% -$5.05K ﹤0.01% 639
2017
Q3 		$34K Buy
591
+2
+0.3% +$114 ﹤0.01% 610
2017
Q2 		$35K Buy
589
+376
+177% +$21.3K ﹤0.01% 600
2017
Q1 		$12K Buy
213
+35
+20% +$1.9K ﹤0.01% 778
2016
Q4 		$9K Sell
178
-764
-81% -$40.8K ﹤0.01% 764
2016
Q3 		$54K Buy
942
+390
+71% +$23.4K 0.01% 402
2016
Q2 		$32K Buy
552
+202
+58% +$11.8K 0.01% 464
2016
Q1 		$20K Buy
+350
New +$20.7K ﹤0.01% 511

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
BCIM
British Columbia Investment Management Victoria, British Columbia, Canada $17B AUM 31.69% 1-Year Est. Return
ERSOT
Employees Retirement System of Texas Austin, Texas $11.4B AUM 21.6% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return

North Star Investment Management's PPH Position: Q1 2026 in Review

North Star Investment Management held its VanEck Pharmaceutical ETF (PPH) position steady in Q1 2026 at 666 shares worth $69.1K. The position accounts for ﹤0.01% of the portfolio, ranked #663.

North Star Investment Management first reported a position in PPH in Q1 2016 and has held it in 40 quarters since. The position peaked at $164K in Q3 2018. 147 funds tracked by Wall St. Rank hold PPH as of Q1 2026.

  • North Star Investment Management held 666 shares of VanEck Pharmaceutical ETF worth $69.1K as of Q1 2026.
  • North Star Investment Management left its VanEck Pharmaceutical ETF share count unchanged in Q1 2026.
  • VanEck Pharmaceutical ETF made up ﹤0.01% of North Star Investment Management's portfolio in Q1 2026, its #663 holding.
  • North Star Investment Management first reported a position in VanEck Pharmaceutical ETF in Q1 2016 and has held it in 40 quarters since.
  • North Star Investment Management's VanEck Pharmaceutical ETF position peaked at $164K in Q3 2018.
  • 147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2026.

Based on North Star Investment Management's 13F filing for Q1 2026, filed 23 Apr 2026.